News Biotech association steps in to fight growth of ‘plausibilit... The UK’s Supreme Court is to allow the UK BioIndustry Association (BIA) to intervene in a long-running legal battle over a drug patent.
Views & Analysis Increasing access to medicines: A critical look at pharmaceu... Extending patents is restricting patients’ access to the treatments they need.
Views & Analysis Making the case for pharmaceutical IP management IP management can protect pharma companies’ investments and future R&D.
Views & Analysis Recent trends in ANDA litigation Sheila Swaroop and Kaitlin Heinen examine the findings of a recent report.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face